Expression of PD‐L1 in tumor‐associated nerves correlates with reduced CD8+tumor‐associated lymphocytes and poor prognosis in prostate cancer

前列腺癌 间质细胞 前列腺 肿瘤微环境 医学 免疫组织化学 免疫系统 CD8型 免疫疗法 癌症研究 病理 间质瘤 癌症 内科学 免疫学
作者
Rujun Mo,Zhaodong Han,Yingke Liang,Jian‐Heng Ye,Shulin Wu,Sharron X. Lin,Yanqiong Zhang,Shengda Song,Funeng Jiang,Weide Zhong,Chin‐Lee Wu
出处
期刊:International Journal of Cancer [Wiley]
卷期号:144 (12): 3099-3110 被引量:47
标识
DOI:10.1002/ijc.32061
摘要

To investigate immune profile consisting of stromal PD‐L1 expression, inhibitory or non‐T‐cell inflamed tumor microenvironment that may predict response to anti‐PD‐L1/PD‐1 immunotherapy in prostate cancer, we validated the specificity of a PD‐L1 monoclonal antibody (E1L3N) and identified PD‐L1 specific expression in prostatic stromal nerve cells. PD‐L1 expression was analyzed in 73 primary prostate cancers and 7 castration‐resistant prostate cancers (CRPC) by immunohistochemistry (IHC) and resulting data from primary prostate cancers were correlated with tumor‐associated lymphocytes (TALs), clinicopathological characteristics and clinical outcome. PD‐L1 was expressed in the tumor cells in only one primary prostate cancer case and none of the CRPC. However, PD‐L1 was frequently observed in the nerve branches in the tumor‐associated stroma (69 of 73 cases, 94.5%), supported by colocalization with axonal marker PGP9.5. FoxP3‐, CD3‐ and CD8‐positive T lymphocytes were observed in 74.6% (47/63), 98.4% (62/63) and 100% (61/61) of the cases, respectively. The density of PD‐L1 + tumor‐associated nerves (TANs) was inversely correlated with that of CD8 + TALs. Higher density of PD‐L1 + TANs was significantly associated with biochemical recurrence (BCR) in Kaplan–Meier survival analysis ( p = 0.016). In both univariate and multivariate Cox analysis, the density of PD‐L1 + TANs was independently prognostic of BCR. In conclusion, PD‐L1 expression is rare in prostate tumor cells but prevalent in TANs and negatively correlated with CD8 + TALs. Neuro‐immunological interaction may be a contribution to immune‐suppressive microenvironment. Combinatorial treatment regimen designs to neural PD‐L1 and TALs should be warranted in future clinical application of anti‐PD‐L1/PD‐1 immunotherapy in prostate cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
量子星尘发布了新的文献求助10
2秒前
hilbertbo发布了新的文献求助20
3秒前
4秒前
4秒前
伴夏完成签到 ,获得积分10
5秒前
科研通AI2S应助kryptonite采纳,获得10
6秒前
了一发布了新的文献求助10
6秒前
Master发布了新的文献求助10
6秒前
刘天玥发布了新的文献求助10
8秒前
9秒前
公孙世往发布了新的文献求助10
10秒前
菜虚鲲完成签到 ,获得积分10
11秒前
大胖完成签到,获得积分10
13秒前
15秒前
老温完成签到,获得积分10
16秒前
19秒前
19秒前
爆米花应助cAMP采纳,获得10
21秒前
23秒前
科研通AI2S应助刘天玥采纳,获得10
24秒前
蔡旭捆完成签到 ,获得积分10
24秒前
25秒前
难过的丹烟完成签到,获得积分10
26秒前
yyy完成签到 ,获得积分10
27秒前
28秒前
深情安青应助学术悍匪采纳,获得10
28秒前
29秒前
Jemma发布了新的文献求助10
31秒前
KinoFreeze完成签到 ,获得积分10
32秒前
丘比特应助山东及时雨采纳,获得10
32秒前
32秒前
怕黑海冬完成签到,获得积分10
33秒前
hilbertbo完成签到,获得积分10
33秒前
34秒前
可爱的函函应助Ortho采纳,获得10
36秒前
俊逸的蛋挞完成签到,获得积分10
36秒前
37秒前
Singularity应助墨菲特采纳,获得10
38秒前
38秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976418
求助须知:如何正确求助?哪些是违规求助? 3520512
关于积分的说明 11203586
捐赠科研通 3257127
什么是DOI,文献DOI怎么找? 1798594
邀请新用户注册赠送积分活动 877804
科研通“疑难数据库(出版商)”最低求助积分说明 806523